hTR RNA component as a marker of cellular proliferation in oral lichen planus

Asian Pacific Journal of Cancer Prevention

Volumn 9, Issue 2, 2008, Pages 287-290

  Flatharta, Cathal Ó ^a,c   Flint, Stephen ^b   Toner, Mary ^b   Mabruk, Mohamed ^a,d  

^a BEAUMONT HOSPITAL   (Ireland)

^b DUBLIN DENTAL UNIVERSITY HOSPITAL   (Ireland)

^c NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^d UNIVERSITI BRUNEI DARUSSALAM   (Brunei Darussalam)

Author keywords

Cellular proliferation; hTR; Marker; Oral lichen planus; Telomerase RNA component

Indexed keywords

HTR RNA; KI 67 ANTIGEN; TELOMERASE; TUMOR MARKER; UNCLASSIFIED DRUG; UNTRANSLATED RNA;

ADULT; ARTICLE; CELL PROLIFERATION; ENZYME IMMUNOASSAY; FEMALE; GENETICS; HUMAN; IN SITU HYBRIDIZATION; LICHEN PLANUS; MALE; METABOLISM; MIDDLE AGED; MOUTH MUCOSA; PATHOLOGY; RNA PROBE;

ADULT; CELL PROLIFERATION; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION; KI-67 ANTIGEN; LICHEN PLANUS, ORAL; MALE; MIDDLE AGED; MOUTH MUCOSA; RNA PROBES; RNA, UNTRANSLATED; TELOMERASE; TUMOR MARKERS, BIOLOGICAL;

EID: 59849099125     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Abbate G, Foscolo AM, Gallotti M, Lancella A, Mingo F (2006). Neoplastic transformation of oral lichen planus: case report and review of the literature. Acta Othrhinolaryngol Ital, 26, 47-2.
2. Belair CD, Yeager TR, Lopez PM and Reznikoff CA (1998). Telomerase activity: a biomarker of cell proliferation, not malignant transformation. Proc Natl Acad Sci USA, 94, 13677.
3. Chang LY, Lin SC, Wong YK, Hu YC, Chang KW (1999). Telomerase activity and in situ telomerase RNA expression in oral carcinogenesis. J Oral Pathol Med, 28, 396.
4. Feng J, Funk WD, Wang SS, et al (1995). The RNA component of human telomerase. Science, 269, 1236.
5. Girod SC, Pfeiffer P, Ries J, Pape HD (1998). Proliferation activity and loss of tumour suppressor genes as "biomarkers" in diagnosis of benign and preneoplastic oral lesions and oral squamous cell carcinoma. Br J Oral Maxillofac Surg, 36, 252.
6. Harrington L, McPhail T, Mar V, et al (1997). A mammalian telomerase-associated protein. Science, 275, 973.
7. Hitchcock CL (1991). Ki-67 staining as a means to simplify analysis of tumor cell proliferation. Am J Clin Pathol. 96, 444-.
8. Hiyama K, Ishioka S, Shirotani Y, et al (1995). Alterations in telomeric repeat length in lung cancer are associated with loss of heterozygosity in p53 and Rb. Oncogene, 10, 937.
9. Holmstrup P (1992). The controversy of the premalignant nature of oral lichen planus is over. Oral Surg Oral Med Oral Pathol, 73, 704.
10. Jarobe EA, Liaw Ki, Thompson LC, et al (2002). Analysis of telomerase as a diagnostic biomarker of cervical dysplasia and carcinoma. Oncogene, 21, 664.
11. Kammori M, Kanauchi H, Nakamura K, et al (2002). Demonstration of human telomerase reverse transcriptase in human colorectal carcinomas by in situ hybridisation. Int J Oncol, 20, 15.
12. Kim NW, Piatyszek MA, Prowse (1994). Specific association of human telomerase activity with immortal cells and cancer. Science, 266, 22011.
13. Kirkpatrick KL, Newbold RF, Mokbel K (2004). The mRNA expression of hTERT in human breast carcinomas correlates with VEGF expression. J Carcinogen, 22;3(1):1.
14. Liao J, Mitsuyasu T, Yamane K, Ohishi M (2000). Telomerase activity in oral and maxillofacial tumours. Oral Oncol, 36, 347.
15. Melissourgos N, Kastrinakis NG, Davilas I, Foukas P, Lykourinas M (2003). Detection of human telomerase reverse transcriptase mRNA in urine of patients with bladder cancer: evaluation of an emerging tumour marker. Urology, 62, 362.
16. Meyerson M, Counter CM, Eaton EN (1997). hEST2, the putative human telomerase catalytic subunit gene, is upregulated in tumour cells and during immortalization. ???, 90,785.
17. Moyzis RK, Buckingham JM, Cram LS, et al (1988). A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proc Natl Acad Sci USA, 85, 6622.
18. Mutirangura A, Supiyaphun P, Trirekapan S, et al (1996). Telomerase activity in oral leukoplakia and head and neck squamous cell carcinoma. Cancer Res, 56, 3530.
19. O'Flatharta C, Leader M, Kay E, et al (2002). Telomerase activity detected in oral lichen planus by RNA in situ hybridisation: not a marker for malignant transformation. J Clin Pathol, 55, 602.
20. Ogoshi M, Le T, Shay JW, Taylor RS (1998). In situ hybridisation analysis of the expression of human telomerase RNA in normal and pathologic conditions of the skin. J Invest Dermatol, 110, 818.
21. Rhyu M (1995). Telomeres, telomerase and immortality. J Natl Cancer Inst, 87, 884.
22. Rijzewijk JJ, Van Erp PE and Bauer FW (1989).Two binding sites for Ki67 related to quiescent and cycling cells in human epidermis. Acta Derm Venereol, 69, 512.
23. Scott RE, Wilke MS, Wille JJ Jr, et al (1988). Human squamous carcinoma cells express complex defects in the control of proliferation and differentiation. Am J Pathol, 133, 374.
24. Snijders PJ, Breuer RH, Sutedja TG (2004). Elevated hTERT mRNA levels: A potential determinant of bronchial squamous cell carcinomas (in situ). Int J Cancer, 109, 412.
25. Sommerfeld HJ, Meeker AK, Piatyszek MA, et al (1996). Telomerase activity: a prevalent marker of malignant human prostate tissue. Cancer Res, 56, 218.
26. Tahara H, Kuniyasu H, Yokozaki H, et al (1995). Telomerase activity in preneoplastic and neoplastic gastric and colorectal lesions. Clin Cancer Res, 1, 1245.
27. Vaziri H, Benchimol S (1998). Reconstitution of telomerase activity in normal human cells leades to elongation of telomerase and extended replicative life span. Curr Biol, 8, 279.